2 Jul 2021
Sartorius Stedim Biotech strengthens product portfolio for cell and gene therapies by acquiring a majority stake in CellGenix
Author: admintech | Filed under: Press ReleaseAUBAGNE, France, July 2, 2021 /PRNewswire/ — Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has acquired a majority stake in the reagent manufacturer CellGenix GmbH. The company based in Freiburg, Germany, and with a sales subsidiary near the…